4//SEC Filing
NEUROCRINE BIOSCIENCES INC 4
Accession 0001209191-15-056014
$NBIXCIK 0000914475operating
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:20 PM ET
Size
8.8 KB
Accession
0001209191-15-056014
Insider Transaction Report
Form 4
MITCHELL W THOMAS
Director
Transactions
- Sale
Common Stock
2015-06-23$49.35/sh−15,000$740,250→ 1,000 total - Exercise/Conversion
Common Stock
2015-06-23$6.66/sh+15,000$99,900→ 16,000 total - Exercise/Conversion
Non-qualified Stock Option
2015-06-23$6.66/sh−15,000$99,900→ 0 totalExercise: $6.66Exp: 2022-05-23→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
- [F2]The option was granted May 23, 2012 and vested in 12 equal monthly installments beginning June 23, 2012.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000914475
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 6:20 PM ET
- Size
- 8.8 KB